Terug
34
17
56
38
50
42
Dagbereik
€ 128,98
€ 132,98
52-Weeksbereik
€ 84,23
€ 160,18
Volume
1.071.802
50D / 200D Gem.
€ 132,64
/
€ 136,96
Vorige Slotkoers
€ 127,86
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 27,5 | 0,3 |
| P/B | 4,1 | 3,0 |
| ROE % | 16,4 | 3,7 |
| Net Margin % | 16,7 | 3,8 |
| Rev Growth 5Y % | 26,0 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 170,36
+29.9%
Low: € 140,00
High: € 195,00
Forward K/W
22,17
Forward WPA
€ 5,91
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,45B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 12,44
€ 11,26 – € 15,00
|
4,64B | 14 |
| FY2029 |
€ 10,61
€ 9,61 – € 12,79
|
4,31B | 14 |
| FY2028 |
€ 10,03
€ 5,64 – € 16,15
|
4,20B | 16 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-11 | € 1,80 | € 1,88 | +4,4% |
| 2025-10-28 | € 1,58 | € 2,04 | +29,1% |
| 2025-07-30 | € 0,98 | € 1,06 | +8,2% |
| 2025-05-05 | € 0,54 | € 0,08 | -85,0% |
| 2025-02-06 | € 1,62 | € 1,00 | -38,3% |
| 2024-10-30 | € 1,51 | € 1,24 | -17,9% |
| 2024-08-01 | € 1,05 | € 0,63 | -40,0% |
| 2024-05-01 | € 1,01 | € 0,42 | -58,4% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 26,04% annually over 5 years — strong growth
Earnings grew 40,23% over the past year
ROE of 16,38% — decent returns on equity
Net margin of 16,73% shows strong profitability
Debt/Equity of 0,13 — conservative balance sheet
Generating 748,70M in free cash flow
Groei
Revenue Growth (5Y)
26,04%
Revenue (1Y)21,45%
Earnings (1Y)40,23%
FCF Growth (3Y)43,89%
Kwaliteit
Return on Equity
16,38%
ROIC12,66%
Net Margin16,73%
Op. Margin21,64%
Veiligheid
Debt / Equity
0,13
Current Ratio3,39
Interest Coverage0,00
Waardering
P/E Ratio
27,50
Forward P/E21,48
P/B Ratio4,05
EV/EBITDA20,78
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21,45% | Revenue Growth (3Y) | 23,12% |
| Earnings Growth (1Y) | 40,23% | Earnings Growth (3Y) | 38,44% |
| Revenue Growth (5Y) | 26,04% | Earnings Growth (5Y) | 52,03% |
| Profitability | |||
| Revenue (TTM) | 2,86B | Net Income (TTM) | 478,60M |
| ROE | 16,38% | ROA | 10,33% |
| Gross Margin | 98,18% | Operating Margin | 21,64% |
| Net Margin | 16,73% | Free Cash Flow (TTM) | 748,70M |
| ROIC | 12,66% | FCF Growth (3Y) | 43,89% |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 3,39 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 27,50 | Forward P/E | 21,48 |
| P/B Ratio | 4,05 | P/S Ratio | 4,60 |
| PEG Ratio | 0,71 | Forward PEG | N/A |
| EV/EBITDA | 20,78 | Fwd EV/EBITDA | 10,10 |
| Forward P/S | 3,82 | Fwd Earnings Yield | 4,66% |
| FCF Yield | 5,69% | ||
| Market Cap | 13,16B | Enterprise Value | 12,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,86B | 2,36B | 1,89B | 1,49B | 1,13B |
| Net Income | 478,60M | 341,30M | 249,70M | 154,50M | 89,60M |
| EPS (Diluted) | 4,67 | 3,29 | 2,47 | 1,56 | 0,92 |
| Gross Profit | 2,81B | 2,32B | 1,85B | 1,47B | 1,12B |
| Operating Income | 619,10M | 570,50M | 250,90M | 249,00M | 102,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 4,63B | 3,72B | 3,25B | 2,37B | 2,07B |
| Total Liabilities | 1,38B | 1,13B | 1,02B | 660,90M | 698,50M |
| Shareholders' Equity | 3,25B | 2,59B | 2,23B | 1,71B | 1,37B |
| Total Debt | 415,30M | 455,10M | 428,40M | 262,90M | 440,40M |
| Cash & Equivalents | 713,00M | 233,00M | 251,10M | 262,90M | 340,80M |
| Current Assets | 2,52B | 1,72B | 1,61B | 1,45B | 972,80M |
| Current Liabilities | 743,40M | 507,70M | 654,80M | 537,70M | 245,80M |
Strategiescores
This stock passed the criteria for 6 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#761 of 1052
Custom
Capital Light Compounder
#211 of 218
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#120 of 332
Custom
Full Throttle
#90 of 146
Custom
Balanced Risk
#56 of 151
Custom
Lower Risk
#90 of 140
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Ingestapt
Full Throttle
Mar 24, 2026
Ingestapt
Balanced Risk
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026